Compare
Mereo BioPharma Group plc vs Lipella Pharmaceuticals Inc. vs Quantum Cyber N.V. vs Silence Therapeutics plc
| Latest fiscal year | Mereo BioPharma Group plc MREO | Lipella Pharmaceuticals Inc. LIPOLast annual report: year ended 2024-12-31 | Quantum Cyber N.V. QUCY | Silence Therapeutics plc SLN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $500.0K | $536.4K | $537.1K | $559.0K |
| Revenue growth (YoY) | n/a | +19.3% | -39.9% | -98.7% |
| Gross margin | n/a | n/a | 72.6% | 61.5% |
| Operating margin | n/m | -947.2% | n/m | n/m |
| Net margin | n/m | -935.2% | n/m | n/m |
| Net income | -$41.88M | -$5.02M | -$16.21M | -$88.61M |
| EPS (Diluted) | -$0.05 | -$4.79 | -$2.70 | -$0.63 |
| Operating cash flow | -$30.97M | -$3.95M | -$10.98M | -$62.27M |
| Free cash flow | -$30.99M | n/a | -$10.98M | -$62.33M |
| Cash & equivalents | $40.99M | $2.18M | n/a | $11.28M |
| Total assets | $45.92M | $2.67M | $5.33M | $131.44M |
| Total liabilities | $5.00M | $754.4K | $4.69M | $69.14M |
| Shareholders' equity | $40.92M | $1.92M | $641.6K | $62.30M |
| Return on year-end equity | -102.4% | -261.3% | n/m | -142.2% |
| Shares outstanding | n/a | 1.21M | 9.78M | 141.70M |
Revenue, most recent five fiscal years
| Fiscal year | Mereo BioPharma Group plc | Lipella Pharmaceuticals Inc. | Quantum Cyber N.V. | Silence Therapeutics plc |
|---|---|---|---|---|
| Latest | $500.0K Ended 2025-12-31 | $536.4K Ended 2024-12-31 | $537.1K Ended 2025-12-31 | $559.0K Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2024-12-31 | $449.6K Ended 2023-12-31 | $894.0K Ended 2024-12-31 | $43.26M Ended 2024-12-31 |
| 2 years earlier | $10.00M Ended 2023-12-31 | $184.2K Ended 2022-12-31 | n/a | $31.64M Ended 2023-12-31 |
| 3 years earlier | $0 Ended 2022-12-31 | $259.3K Ended 2021-12-31 | n/a | $21.66M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | n/a | n/a |